Amgen Successfully Completes Acquisition Of Five Prime Therapeutics
THOUSAND OAKS, Calif., April 16, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of common stock of Five Prime Therapeutics (NASDAQ:FPRX), a clinical-stage biotechnology…
Comments Off on Amgen Successfully Completes Acquisition Of Five Prime Therapeutics